BLOOD RESEARCH

2020	Vol. 55 No. 1 1-9	Vol. 55 No. 2 107-98	Vol. 55 No. S1 S1-S82
2019	Vol. 54 No. 1 1-9	Vol. 54 No. 2 102-86	Vol. 54 No. 3 159-240	Vol. 54 No. 4 241-295
2018	Vol. 53 No. 1 1-94	Vol. 53 No. 2 101-181	Vol. 53 No. 3 183-264	Vol. 53 No. 4 265-336
2017	Vol. 52 No. 1 1-9	Vol. 52 No. 2 100-99	Vol. 52 No. 3 151-233	Vol. 52 No. 4 235-339
2016	Vol. 51 No. 1 1-68	Vol. 51 No. 2 102-94	Vol. 51 No. 3 149-214	Vol. 51 No. 4 215-299
2015	Vol. 50 No. 1 1-65	Vol. 50 No. 2 103-96	Vol. 50 No. 3 123-185	Vol. 50 No. 4 187-267
2014	Vol. 49 No. 1 1-73	Vol. 49 No. 2 100-99	Vol. 49 No. 3 139-207	Vol. 49 No. 4 209-285
2013	Vol. 48 No. 1 1-7	Vol. 48 No. 2 107-98	Vol. 48 No. 3 165-234	Vol. 48 No. 4 235-303

The Korean Journal of Hematology: 1966 (v1 n1) to 2012 (v47 n4)

2010s

201020112012

2000s

2000200120022003200420052006200720082009

1990s

1990199119921993199419951996199719981999

1980s

1980198119821983198419851986198719881989

1970s

1970197119721973197419751976197719781979

1960s

1966196719681969

Volume & Number

August 4, 2020

ahead

Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression

Shuku Sato, Yotaro Tamai

https://doi.org/10.5045/br.2020.2020045

PDF

ahead

Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression

Shano Naseem, Vishrut KS, Neelam Varma, Pankaj Malhotra

https://doi.org/10.5045/br.2020.2020080

PDF

ahead

Hb-M Hyde Park: a rare cause of cyanosis arising from a de novo mutation

Loveena Rastogi, Sabina Langer, Nita Radhakrishnan, Renu Saxena, Jyoti Kotwal

https://doi.org/10.5045/br.2020.2020084

PDF

ahead

Peripheral blood histoplasmosis in an immunocompetent child with disseminated disease

Richa Chauhan, Soma Pradhan, Jyoti Kotwal, Kunal Chawla, Manas Kalra, Anupam Sachdev

https://doi.org/10.5045/br.2020.2020134

PDF

Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome

Hyun Gyung Lee, Hee Jo Baek, Ho Sung Kim et al.

Blood Res 2019; 54(1): 63-73

PDF

PubMed Central

Spectrum of mitochondrial genome instability and implication of mitochondrial haplogroups in Korean patients with acute myeloid leukemia

Hye Ran Kim, Min-Gu Kang, Young Eun Lee et al.

Blood Res 2018; 53(3): 240-249

PDF

PubMed Central

Supplementary File

Recent progress in laboratory diagnosis of thalassemia and hemoglobinopathy: a study by the Korean Red Blood Cell Disorder Working Party of the Korean Society of Hematology

Young Kyung Lee, Hee-Jin Kim, Kyunghoon Lee et al.

Blood Res 2019; 54(1): 17-22

PDF

PubMed Central

Molecular perspective of iron uptake, related diseases, and treatments

Negin Shokrgozar, and Habib Allah Golafshan

Blood Res 2019; 54(1): 10-16

PDF

PubMed Central

Recurrent bilateral deep vein thrombosis after cava vein resection in a patient with leiomyosarcoma

Lucia Ordieres-Ortega, Pablo Demelo-Rodríguez, Sandra Piqueras-Ruiz et al.

Blood Res 2019; 54(1): 1-1

PDF

PubMed Central

Multiple myeloma in Korea: risk stratification and initial treatment

Sung-Soo Yoon, M.D., Ph.D.

Blood Res 2018; 53(3): 183-184

PDF

PubMed Central

Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission

Juae Shin, Na Yeong Lee, Seongkoo Kim et al.

Blood Res 2019; 54(1): 45-51

PDF

PubMed Central

Supplementary File

Biochemical effects and safety of Gum arabic (Acacia Senegal) supplementation in patients with sickle cell anemia

Lamis AbdelGadir Kaddam, Imad Fdl-Elmula, Omer Ali Eisawi et al.

Blood Res 2019; 54(1): 31-37

PDF

PubMed Central

Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico

José Carlos Jaime-Pérez, Patrizia Aguilar-Calderón, Lorena Salazar-Cavazos et al.

Blood Res 2019; 54(2): 131-136

PDF

PubMed Central

Cytoplasmic azurophilic inclusion bodies in reactive plasmacytosis

Aastha Gupta, Preeti Tripathi, and Seema Tyagi

Blood Res 2018; 53(4): 265-265

PDF

PubMed Central

Efficacy of parenteral glutamine supplementation in adult hematopoietic stem cell transplantation patients

Yun Kyung Cho, So Yeon Hong, Su Jeoung Jeon et al.

Blood Res 2019; 54(1): 23-30

PDF

PubMed Central

Supplementary File

Clonal villous lymphocytes and plasma cells in splenic marginal zone lymphoma with plasmacytic differentiation

João Tadeu Damian Souto Filho, Rodrigo Aires de Morais, Ana Laura Oliveira Silveira et al.

Blood Res 2018; 53(4): 267-267

PDF

PubMed Central

Breast implant-associated anaplastic large cell lymphoma

Lucile Baseggio, Alexandra Travers-Glehen, Emmanuel Bachy et al.

Blood Res 2019; 54(1): 3-3

PDF

PubMed Central

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes

Kyoung Il Min, Silvia Park, Seung-Hwan Shin et al.

Blood Res 2019; 54(2): 102-107

PDF

PubMed Central

Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience

Jihoon Kang, Jung Yong Hong, and Cheolwon Suh

Blood Res 2018; 53(3): 189-197

PDF

PubMed Central

Supplementary File

No	Title
1	Hematopoietic stem cell expansion and generation: the ways to make a breakthrough Bokyung Park, Keon Hee Yoo, and Changsung Kim Blood Res 2015; 50(4): 194-203
2	First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia Da Jung Kim, Seri Jeong, Seom Gim Kong, Ho Sup Lee Blood Res 2019; 54(2): 151-153
3	Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma Munira Shabbir-Moosajee, Samad Jehangir, Sobiya Sawani, Tariq Muhammed, Natasha Ali, Usman Sheikh, Salman Adil Blood Res 2019; 54(2): 108-113
4	What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness Naohiro Sekiguchi, Airi Hamano, Tomoko Kitagawa, Kenichi Ito, Kazuhiko Hirano, Kazuaki Yamada Blood Res 2019; 54(2): 153-156
5	Enhanced polo-like kinase 1 expression in myelodysplastic syndromes Kyoung Il Min, Silvia Park, Seung-Hwan Shin, Yong-Rim Kwon, Hye-Joung Kim, Yoo Jin Kim Blood Res 2019; 54(2): 102-107
6	Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico José Carlos Jaime-Pérez, Patrizia Aguilar-Calderón, Lorena Salazar-Cavazos, Andrés Gómez-De León, David Gómez-Almaguer Blood Res 2019; 54(2): 131-136
7	An investigation of methylation pattern changes in the IKZF1 promoter in patients with childhood B-cell acute lymphoblastic leukemia Mina Rahmani, Masoumeh Fardi, Majid Farshdousti Hagh, Abbas Ali Hosseinpour Feizi, Mehdi Talebi, Saeed Solali Blood Res 2019; 54(2): 144-148
8	Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases Yu Ling Lee-Tsai, Rodrigo Luna-Santiago, Roberta Demichelis-Gómez, Alfredo Ponce-de-León, Eric Ochoa-Hein, Karla María Tamez-Torres, María T Bourlon, Christianne Bourlon Blood Res 2019; 54(2): 120-124
9	Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma Mahsa Eskandari, Saba Manoochehrabadi, Hossein Pashaiefar, Mohammad Ali Zaimy, Mohammad Ahmadvand Blood Res 2019; 54(2): 114-119
10	Chimeric antigen T cell receptor treatment in hematological malignancies Natasha Ali, FCPS Haematology Blood Res 2019; 54(2): 81-83

Current Issue